DOI QR코드

DOI QR Code

Treatment of Atopic Dermatitis Associated with Malassezia sympodialis by Green Tea Extracts Bath Therapy: A Pilot Study

  • 투고 : 2012.04.10
  • 심사 : 2012.04.12
  • 발행 : 2012.06.30

초록

Multiple treatment modalities, including topical and systemic corticosteroid and phototherapy, have been used in treatment of patients with atopic dermatitis. However, long-term corticosteroid therapy may have various adverse effects. The purpose of this study was to investigate the therapeutic efficacy and safety of bath therapy using green tea extracts for treatment of patients with atopic dermatitis. A total of four patients with atopic dermatitis were enrolled in this study. A Malassezia multiplex detection kit was used in performance of multiplex PCR on clinical isolates, which confirmed Malassezia sympodialis. Subjects underwent treatment with bath therapy using green tea extracts three times per wk for a period of 4 wk. Assessment using the scoring atopic dermatitis (SCORAD) index, the visual analogue scale for pruritus, and transepidermal water loss was performed weekly. Laboratory tests were performed before and after treatment. All patients showed marked improvement on the mean SCORAD and visual analogue scale, and a significant decrease in the mean values of serum eosinophil counts was observed after treatment. Bath therapy with green tea extract is an effective, safe, and nonsteroidal therapy for treatment of patients with atopic dermatitis associated with Malassezia sympodialis.

키워드

참고문헌

  1. James W, Berger T, Elston DM. Andrews' diseases of the skin: clinical dermatology. 10th ed. Philadelphia: W. B. Saunders; 2006. p. 789.
  2. Hara Y, Matsuzaki T, Suzuki T. Angiotensin I converting enzyme inhibiting activity of tea components. J Agric Chem Soc Jpn 1987;61:803-8.
  3. Matsuzaki T, Hara Y. Antioxidative activity of tea leaf catechins. J Agric Chem Soc Jpn 1985;59:129-34.
  4. Xu Y, Ho CT, Amin SG, Han C, Chung FL. Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis in A/J mice by green tea and its major polyphenol as antioxidants. Cancer Res 1992;52:3875-9.
  5. Majoie IM, Oldhoff JM, van Weelden H, Laaper-Ertmann M, Bousema MT, Sigurdsson V, Knol EF, Bruijinzeel-Koomen CA, de Bruin-Weller MS. Narrowband ultraviolet B and medium-dose ultraviolet A1 are equally effective in the treatment of moderate to severe atopic dermatitis. J Am Acad Dermatol 2009;60:77-84. https://doi.org/10.1016/j.jaad.2008.08.048
  6. Kindo AJ, Sophia SK, Kalyani J, Anandan S. Identification of Malassezia species. Indian J Med Microbiol 2004;22:179-81.
  7. Gueho E, Midgley G, Guillot J. The genus Malassezia with description of four new species. Antonie van Leeuwenhoek 1996;69:337-55. https://doi.org/10.1007/BF00399623
  8. Kim HM, Lim YY, Park EJ, Chun YJ, Kim MN, Kim BJ, Lee DH. The development and evaluation of multiplex PCR technique for identification of Malassezia yeast. Korean J Med Mycol 2010;15:51-60.
  9. Yun YP, Kang WS, Lee MY. The antithrombotic effects of green tea catechins. J Food Hyg Saf 1996;11:77-82.
  10. Kang WS, Chung KH, Chung JH, Lee JY, Park JB, Zhang YH, Yoo HS, Yun YP. Antiplatelet activity of green tea catechins is mediated by inhibition of cytoplasmic calcium increase. J Cardiovasc Pharmacol 2001;38:875-84. https://doi.org/10.1097/00005344-200112000-00009
  11. Hisano M, Yamaguchi K, Inoue Y, Ikeda Y, Iijima M, Adachi M, Shimamura T. Inhibitory effect of catechin against the superantigen staphylococcal enterotoxin B (SEB). Arch Dermatol Res 2003;295:183-9. https://doi.org/10.1007/s00403-003-0411-x
  12. Ahn KJ. Taxonomy of the genus Malassezia. Korean J Med Mycol 1998;3:81-8.
  13. Gupta AK, Batra R, Bluhm R, Boekhout T, Dawson TL Jr. Skin diseases associated with Malassezia species. J Am Acad Dermatol 2004;51:785-98. https://doi.org/10.1016/j.jaad.2003.12.034
  14. Broberg A, Faergemann J, Johansson S, Johansson SG, Strannegard IL, Svejgaard E. Pityrosporum ovale and atopic dermatitis in children and young adults. Acta Derm Venereol 1992;72:187-92.
  15. Jensen-Jarolim E, Poulsen LK, With H, Kieffer M, Ottevanger V, Stahl Skov P. Atopic dermatitis of the face, scalp, and neck: type I reaction to the yeast Pityrosporum ovale? J Allergy Clin Immunol 1992;89(1 Pt 1):44-51 https://doi.org/10.1016/S0091-6749(05)80039-9
  16. Schmidt M, Zargari A, Holt P, Lindbom L, Hellman U, Whitley P, van der Ploeg I, Harfast B, Scheynius A. The complete cDNA sequence and expression of the first major allergenic protein of Malassezia furfur, Mal f 1. Eur J Biochem 1997;246:181-5. https://doi.org/10.1111/j.1432-1033.1997.00181.x
  17. Yasueda H, Hashida-Okado T, Saito A, Uchida K, Kuroda M, Onishi Y, Takahashi K, Yamaguchi H, Takesako K, Akiyama K. Identification and cloning of two novel allergens from the lipophilic yeast, Malassezia furfur. Biochem Biophys Res Commun 1998;248:240-4. https://doi.org/10.1006/bbrc.1998.8944
  18. Del Rosso JQ. Understanding skin cleansers and moisturizers: the correlation of formulation science with the art of clinical use. Cosmet Dermatol 2003;16:19-31.
  19. Abeck D, Mempel M. Staphylococcus aureus colonization in atopic dermatitis and its therapeutic implications. Br J Dermatol 1998;139(Suppl 53):13-6. https://doi.org/10.1046/j.1365-2133.1998.1390s3013.x
  20. Klein PA, Clark RA, Nicol NH. Acute infection with Trichophyton rubrum associated with flares of atopic dermatitis. Cutis 1999;63:171-2.
  21. Skov L, Baadsgaard O. The potential role of Staphylococcus aureus superantigens in atopic eczema. J Eur Acad Dermatol Venereol 1996;7(Suppl 1):S8-11. https://doi.org/10.1016/0926-9959(96)00028-1